Trans American Aquaculture (GRPS) Gross Profit (2023 - 2024)
Trans American Aquaculture (GRPS) reported Gross Profit of $114736.0 for Q4 2024, up 171.7% on a YoY basis from $42228.6 in Q1 2024, and up 158.37% quarter-over-quarter from -$196552.0 in Q3 2024.
Trans American Aquaculture (GRPS) Gross Profit (2023 - 2024) Analysis & Trends
Trans American Aquaculture has reported Gross Profit for 2 years, with the latest figure at $114736.0 in Q4 2024.
- For the quarter ending Q4 2024, Gross Profit rose 171.7% year-over-year to $114736.0; the trailing twelve-month figure through Sep 2025 stood at $114736.0 (up 136.39% YoY), and the FY2024 full-year result was $10030.0, up 101.79% from the prior year.
- Gross Profit for Q4 2024 stood at $114736.0, up from -$196552.0 in the prior quarter.
- The five-year high for Gross Profit was $114736.0 in Q4 2024, with the low at -$400000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Trans American Aquaculture | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 114,736.00 |
| Dec 31, 2024 | 114,736.00 |
| Sep 30, 2024 | -196,552.00 |
| Sep 30, 2024 | -196,552.00 |
| Jun 30, 2024 | 3,248.00 |
| Jun 30, 2024 | 3,248.00 |
| Mar 31, 2024 | 38,047.00 |
| Mar 31, 2024 | 38,047.00 |
| Dec 31, 2023 | -160,018.00 |
| Dec 31, 2023 | -160,018.00 |
| Sep 30, 2023 | -400,000.00 |
| Sep 30, 2023 | -400,000.00 |